Navigation Links
SPO Partners with HoMedics LLC

NEW YORK, February 19, 2013 /PRNewswire/ --

SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today that it has partnered with HoMedics LLC for the distribution of a private-labeled, over-the-counter (OTC) pulse oximeter for non-medical consumer wellness applications. This new product, known as the HoMedics Deluxe Pulse Oximeter is currently being promoted and sold in North America.

The oximeter is based on patented Optimetrix™ technology which uses proprietary optical techniques to measure certain vital sign measurements for a variety of consumer wellness applications.  In the United States, the Deluxe Pulse Oximeter was launched during 4th quarter 2012 at CVS stores, and HoMedics sees substantial upside potential to expand in the drug channel and beyond during 2013. Furthermore, HoMedics will look to increase distribution worldwide via its extensive network in over 60 countries.

Michael Braunold, Chief Executive Officer of SPO commented: "We've been working with HoMedics since early summer 2012 and have made tremendous progress together, with the successful introduction of the HoMedics Deluxe Pulse Oximeter to US consumers.  As market awareness for wellness products strengthens and grows, our partnership with the oximeter and future products under development creates promising opportunities for both companies. Our decision to distribute under the HoMedics private-label has afforded us access to mass-market retailers worldwide and we plan on expanding our product portfolio to further leverage on our joint-success to date".

SPO views the general wellness product category as a major growth opportunity by leveraging its technology to monitor information related to general leisure/sport activities. Product opportunities currently under development include a fitness watch which negates the need for the traditional chest-strap currently being used by most sports watch manufacturers, and a new consumer wellness time-piece designed to measure overall daily activity level, especially useful for overweight or obese adults and children. This product will include unique innovative features as well as being a fashionable time-piece to continuously measure the number of daily activities and calories burned against a recommended goal.

About SPO

SPO (SPOM) is a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-enhancing information within four key markets: medical care; sports and wellness; homecare monitoring and security. Its patented technology uses information gathered from the reflectance of light on the human body, in a noninvasive manner, to monitor key vital signs. The company manufactures its products in addition to licensing its technologies to appropriate client corporations for commercialization and distribution. For more information, visit

About HoMedics

HoMedics is a privately held, family-owned business founded in 1987 that manufactures and markets some of the world's best known, most innovative brands in an array of consumer health, wellness and electronics lifestyle categories. HoMedics distributes its products to more than 60 countries throughout North America, South America, Central America, the Asia-Pacific region, Europe, Africa and the Middle East. For more information, visit

Forward Looking Statements

This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, the realization of revenues from product orders for the HoMedics Deluxe Pulse Oximeter, the success of efforts to expand distribution of the product, the success, if any, of our efforts to expand distribution of the product to additional mass market retailers, the ability to create strategic partnerships to aid in the distribution of products, profitability, market acceptance of our products and new product applications, timing of new product launches, success of the Company's rebranding program, product performance, size of prospective markets, revenue assessments, marketing strategies, success of our restructured operations and plans, our ability to generate fees or raise capital to support our business operations and plan, the sufficiency and availability of working capital, changes in economic conditions generally and in more specifically, the introduction of competing products, changes in our operating strategy or development plans patent protection for our products and technologies, changes in economic conditions generally and in more specifically, in the markets we operate, changes in technology, legislative or regulatory changes that affect us and the risks and uncertainties discussed under the heading "Risk Factors" in Item 1 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2011. We undertake no obligation to revise or update any forward-looking statement for any reason.


Contact regarding this release:    


SOURCE SPO Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products
2. Unigene Receives 2013 Drug Delivery Partnerships Industry Achievement Award
3. Unigene Recieves 2013 Drug Delivery Partnerships Industry Achievement Award
4. NASP Announces Partnership with Gerry Crocker to Advance Specialty Pharmacy Industry
5. Renowned Photographer and HIV Activist Duane Cramer Partners with Project Runway Star Mondo Guerra and Merck on I Design Campaign
6. ADL Data Systems Partners With COMS Interactive, LLC
7. H. D. Smith Specialty Solutions Appoints 20-year Industry Veteran Tim Booth To Executive Vice President, Smith Medical Partners
8. Henry Schein, Supplier Partners Join American Dental Association On Eleventh Annual Give Kids A Smile Day
9. Linden Capital Partners Completes Acquisition of Young Innovations, Inc.
10. Pro-Dex, Inc. And AO Partners Group Jointly Announce Voting Results
11. Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation
Post Your Comments:
(Date:12/1/2015)... , December 1, 2015 ... new market research report "Nucleic Acid Labeling Market by ... Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, ... published by MarketsandMarkets, The global market is expected to ... Million in 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , December 1, 2015 Russia ... clinical trials. 70% of new drugs registered in Europe ... Russia . --> Russia has always been ... of new drugs registered in Europe in 2015 ... --> Russia has always been a country ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
Breaking Medicine Technology:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... in the 1980s we have seen vast improvements in scientific research and discoveries, ... significant strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), ... at the Radiological Society of North America (RSNA) 2015 annual meeting through December ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech ... . Gary has spent a significant amount of time in Sweden since joining ...
Breaking Medicine News(10 mins):